A review of polysaccharide cytotoxic drug conjugates for cancer therapy N Goodarzi, R Varshochian, G Kamalinia, F Atyabi, R Dinarvand Carbohydrate polymers 92 (2), 1280-1293, 2013 | 166 | 2013 |
Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel S Manoochehri, B Darvishi, G Kamalinia, M Amini, M Fallah, SN Ostad, ... DARU Journal of Pharmaceutical Sciences 21, 1-10, 2013 | 145 | 2013 |
Growth factor conjugation: strategies and applications M Hajimiri, S Shahverdi, G Kamalinia, R Dinarvand Journal of biomedical materials research Part A 103 (2), 819-838, 2015 | 86 | 2015 |
Enhanced brain delivery of deferasirox–lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies G Kamalinia, F Khodagholi, F Atyabi, M Amini, F Shaerzadeh, ... Molecular pharmaceutics 10 (12), 4418-4431, 2013 | 68 | 2013 |
Preparation and antibacterial activity evaluation of 18-β-glycyrrhetinic acid loaded PLGA nanoparticles B Darvishi, S Manoochehri, G Kamalinia, N Samadi, M Amini, ... Iranian journal of pharmaceutical research: IJPR 14 (2), 373, 2015 | 63 | 2015 |
Targeted poly (l-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells F Tavassolian, G Kamalinia, H Rouhani, M Amini, SN Ostad, ... International journal of pharmaceutics 467 (1-2), 123-138, 2014 | 54 | 2014 |
Directing evolution of novel ligands by mRNA display G Kamalinia, BJ Grindel, TT Takahashi, SW Millward, RW Roberts Chemical Society Reviews 50 (16), 9055-9103, 2021 | 49 | 2021 |
Formulation and in vitro evaluation of curcumin-lactoferrin conjugated nanostructures for cancerous cells F Chaharband, G Kamalinia, F Atyabi, SA Mortazavi, ZH Mirzaie, ... Artificial cells, nanomedicine, and biotechnology 46 (3), 626-636, 2018 | 41 | 2018 |
Cationic albumin‐conjugated chelating agent as a novel brain drug delivery system in neurodegeneration G Kamalinia, F Khodagholi, F Shaerzadeh, F Tavssolian, F Chaharband, ... Chemical Biology & Drug Design 86 (5), 1203-1214, 2015 | 38 | 2015 |
The ethnopharmacological study on antibacterial activity of some selected plants used in Iranian traditional medicine AMM Ahmadian, EHR Monsef, GHR AMIN, MR Fazeli, H Jamalifar, ... Journal of Medicinal Plants 8 (31), 50-57, 2009 | 20 | 2009 |
Preclinical development of a nontoxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment R Saxena, C Yang, M Rao, RC Turaga, C Garlapati, SR Gundala, K Myers, ... Clinical Cancer Research 23 (14), 3781-3793, 2017 | 14 | 2017 |
mRNA display Discovery of a novel programmed death ligand 1 (PD-L1) binding peptide (a peptide ligand for PD-L1) G Kamalinia, BJ Engel, A Srinivasamani, BJ Grindel, JN Ong, MA Curran, ... ACS chemical biology 15 (6), 1630-1641, 2020 | 13 | 2020 |
N-(1-Naphthyl)ethylenediamine, a New UV Labeling Reagent Used for LC Determination of Valproic Acid in Human Plasma G Kamalinia, MR Rouini, P Ghaeli, M Amini Chromatographia 70, 569-573, 2009 | 9 | 2009 |
Antifungal and antibacterial activities of Pentanema divaricatum and its active constituent N Momen-Roknabadi, AR Gohari, HR Monsef-Esfehani, F Attar, ... Zeitschrift für Naturforschung C 63 (9-10), 649-652, 2008 | 8 | 2008 |
Three years evaluation of drug shortages from educational pharmacies in Tehran K Gholami, G Kamalinia, MMA Attari, J Salamzadeh Iranian Journal of Pharmaceutical Research: IJPR 11 (2), 565, 2012 | 6 | 2012 |
Recent approaches to overcoming multiple drug resistance in breast cancer using modified liposomes R Dinarvand, R Varshochian, G Kamalinia, N Goodarzi, F Atyabi Clinical Lipidology and Metabolic Disorders 8 (4), 391, 2013 | 4 | 2013 |
Serum levels of sodium valproate in patients suffering from bipolar disorders: comparing acute and maintenance phases of mania G Kamalinia, S Brand, P Ghaeli, N Abedi, H Bajoghli, V Sharifi, ... Pharmacopsychiatry 46 (03), 83-87, 2013 | 3 | 2013 |
A comparative study on uterus and kidney inflammation and their treatments described in the book" Hidayat al-Muta'allimin fit-Tib" with modern medicine. MM Ahmadian-Attari, G Kamalinia, M Mosaddegh, H Farsam | 1 | 2010 |
Pd-l1 binding peptides T Takahashi, RW Roberts, G Kamalinia, ONG Justin, B Grindel, B Engel, ... US Patent App. 17/997,507, 2023 | | 2023 |
Selective peptide binders for PDL1 as an immunogenic target in cancer G Kamalinia, T Takahashi, R Roberts ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |